We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.15 | -1.62% | 9.10 | 8.70 | 9.50 | 9.25 | 9.10 | 9.25 | 321,812 | 14:04:44 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.05 | 84.43M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/8/2023 10:50 | I'm still undecided about the value of Elliot waves.What I do know from observation and experience is that whenever Inan repeats his preposterous predictions, the share price tanks. Inan, £8 is YOUR fantasy, please don't try an suck any more hapless punters into it. | ruckrover | |
03/8/2023 08:38 | the numbers are staggering ....... if we hit the sweet spot | inanaco | |
03/8/2023 08:36 | and of course Merck does not have a clue on values eh Loz !! whats 1.5 billion dollars per year ... in lost sales !!!! and you certainly don't, stick with your wood drying hobby | inanaco | |
03/8/2023 08:33 | How effective is KEYTRUDA for head and neck cancer? Keytruda Precision Cancer Immunotherapy Treatment for Head ... The trial evaluated the effectiveness of Keytruda in the treatment of 192 patients with metastatic or recurrent HNSCC. Anti-cancer responses were achieved in 18% of patients. 85% of anti-cancer responses lasted for at least 6 months, and 71% of anti-cancer responses lasted for at least one year.3 Aug 2022 your problem Loz is you don;t look at the market .... what is the effect of those numbers above ... well i will tell you ..$1.5 billion from one indication so what is it worth if you can make it work ? Merck & Co. has failed in an attempt to repeat Keytruda’s metastatic head and neck cancer success in locally advanced disease. But experts still see reasons to keep their hopes up for the drug in early stages of this tumor type. Adding Keytruda to standard chemoradiation therapy showed a positive trend toward delaying disease worsening in locally advanced head and neck squamous cell carcinoma. But the combination only pared down the risk of disease progression or death by 17% over chemoradiation alone, failing to cross the statistical significance threshold. In patients whose tumors expressed PD-L1, the Keytruda combo performed better, with a 20% reduction in the risk of progression or death over chemoradiation alone. Those with PD-L1-negative tumors experienced no obvious difference between the two treatment arms. The results, from the Keynote-412 trial, are presented at the ongoing European Society for Medical Oncology congress 2022. Because of the failure, SVB Securities analyst Daina Graybosch, Ph.D., has removed $1.5 billion from Keytruda’s peak sales estimate. But not all is lost. | inanaco | |
03/8/2023 08:04 | GUFFAW - "£8 is still on the cards .." Yeah right Napoleon Now take YOUR tablets ... | the real lozan | |
03/8/2023 07:02 | If over the next few months we start seeing spectacular results using Checkpoints with synergy it all changes Scancell will have saved the checkpoint in indications that it has failed in, and patients that have also failed it as a mono or in combo with non immunotherapy agents like chemo hence they are on our trial we are treating "failed standard of care" except for the adjuvant arms (surgical removal after 6 weeks) and how many checkpoints are there ? and how many Moditopes ? why are checkpoints so valuable one drug can be used for multiple cancers whats moditope ? ATB | inanaco | |
02/8/2023 21:54 | But he might miss a wave mate. | dominiccummings | |
02/8/2023 15:40 | So, let me see. All those expert and professional investment managers, all the wealthy managed funds, all the private investors that continue to get wealthier are either working on waves or consulting 2ticks? But they waste their time on company information, balance sheets, board appointments and management records. They just don't know their business then do they? | dominiccummings | |
02/8/2023 15:32 | Of course you agree with me knocker old sport....you wouldn't be following me around if you didn't. Your problem is that you don't have the weapons to improve your game...so your learning slowly as you follow me ! We've had this Convo on size before....it's trading volumes that's important. Unless 'emotional attachment' is very strong, as it is with SCLP (just ask the clappers). You may maintain that size isn't important. At your age it probably isn't. I maintain size IS important...lol | 2tyke | |
02/8/2023 14:45 | Tyke, I agree with you !!! I suppose that, by the law of averages, this day has had to come, but it has been a long, long wait. I am intrigued though to know how you would identify a stock as 'tiny' in order to avoid it? The only information you use to to make investment decisions is the price, isn't it? Size comes under the heading 'fundamentals', not 'wiggles and waves' me old son. | 1knocker | |
02/8/2023 14:25 | Chasing moonshots from tiny Aim stocks is the route to the poor house. It is NOT a viable method....and breeds bad discipline....the stock market equivalent of BET365. The bulk of your investments will get decimated....just ask emptyend the clapper. The success stories ..irrelevant in the scheme of things. | 2tyke | |
02/8/2023 14:08 | The reality with Tesla is that I would probably have sold it long ago....and I certainly wouldn't have $8mn in a single stock.I've had some big six figure gains in single stocks though - and expect to do so again here in due course. | markingtime | |
02/8/2023 13:52 | markingtime, I sympathise. Isn't it always the way that it is the stock one thought about buying but did not which goes to the moon!! But would one have held through thick and thin? I try to comfort myself by thinking about the stocks i nearly bought but did not which went in the other direction! Somehow its the missed winners which stick in the mind though. As my old Mum used to say 'Most of the time we should be grateful not to get our just deserts'. | 1knocker | |
02/8/2023 13:49 | Yep....the 152nd birthday of the great man himself....Ralph Nelson Elliott. But changing mainstream 'belief' today is still impossible ...the herding effect is way too strong in humans. They thrive on confirmation bias and 'safety in numbers'....even though being in the majority is really really bad in the markets ! Yep...they still crave news, even though that doesn't drive prices. You'll gain far more insight from a wave pattern than anything you'll hear about ! | 2tyke | |
02/8/2023 13:08 | Exactly right Lozan...pure confirmation bias....all sheep following along. They think that listening to 'research' on companies can give them an edge....even though ALL the evidence tells them otherwise ! Ignore the fundamental nonsense and noise....look to what works ! Ignore those who try and discredit the DATA.....look to those who call it ....in advance ! | 2tyke | |
02/8/2023 13:03 | Good points, 1knocker.Anybody who thinks he "has a system" doesn't, for the reasons you list.Sometimes, though, stocks DO "go to the moon". I am someone who seriously considered buying Tesla shares 13 years ago but didn't. I bought something else instead.When I want to depress myself, I calculate the opportunity cost ($8mn, last time I did it). | markingtime | |
02/8/2023 10:33 | lozan, I agree, up to a point. Even when reading top posts the critical faculties need to be engaged. By its very nature a company specific bb will be populated largely by holders of /enthusiasts for the shares. Many posts will be over-optimistic prophesies which the posters hope will be self-fulfilling, and will be enthusiastically endorsed by others of a like mind. When words of warning (whether about the share or individual posters' methodology and predictions) are widely endorsed though, those posts should at least provide food for thought, and engender caution and sometimes outright scepticism. PIs lose a lot of money piling into moonshots, and trusting to dogmatic assertions from anonymous self proclaimed gurus who claim either inside knowledge or to have infallible systems which invariably 'play out exactly' and 'keep them always on the right side of the market'. These people are like a rash on the internet; for some reason though (I'll leave it to the rest of you to ponder what that reason might be) they are not snapped up at huge salaries as fund managers, to work their magic and take hedge funds , investment trusts and unit trusts to the moon! If those boasts were true, or even partly true, those people would not be posting on bbs, they would be too busy thinking of new ways to spend their money half as fast as the tidal wave of profits rolls into their accounts each and every month. Remember, you heard it from Tyke: its the boasting he enjoys and which he is here for. I am sure he would not let a trivial consideration like truth get in the way of that source of self gratification. | 1knocker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions